ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer

Abstract

Although early detection and systemic therapies have improved the diagnosis and clinical cure rate of breast cancer, breast cancer remains the most frequently occurring malignant cancer in women due to a lack of sufficiently effective treatments. Thus, to develop potential targeted therapies and thus benefit more patients, it is helpful to understand how cancer cells work. ZIC family members have been shown to play important roles in neural development and carcinogenesis. In our study, we found that ZIC2 is downregulated in breast cancer tissues at both the mRNA and protein levels. Low expression of ZIC2 was correlated with poor outcome in breast cancer patients and serves as an independent prognostic marker. Furthermore, overexpression of ZIC2 repressed, whereas knockdown of ZIC2 promoted, cell proliferation and colony formation ability in vitro and tumor growth in vivo. Using ChIP-seq and RNA-seq analysis, we screened and identified STAT3 as a potential target for ZIC2. ZIC2 bound to the STAT3 promoter and repressed the promoter activities of STAT3. ZIC2 knockdown induced the expression of STAT3, increasing the level of phosphorylated STAT3. These results suggest that ZIC2 regulates the transcription of STAT3 by directly binding to the STAT3 promoter. Additionally, interfering STAT3 with siRNAs or inhibitors abrogated the oncogenic effects induced by decreased ZIC2. Taken together, our results indicate that ZIC2 serves as a useful prognostic marker in breast cancer and acts as a tumor suppressor by regulating STAT3, implying that STAT3 inhibitors might provide an alternative treatment option for breast cancer patients with ZIC2 downregulation. *Z.-H.L., M.-L.C., Q.Z. and Y.Z contributed equally to this work. Additional Supporting Information may be found in the online version of this article. hairpin RNA; si: small interfering RNA; STAT3: signal transducers and activators of transcription 3; ZIC: zinc finger protein of the cerebellum

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

“…Cheng et al have shown that CAFs may recruit neutrophils and induce PD-L1 + neutrophils through the IL-6 -STAT3 pathway which facilitates immune suppression in hepatocellular carcinoma (297). STAT3 is known to affect tumor growth and invasion and the JAK/STAT3 pathway is activated in various cancer types (298)(299)(300). CAFs were recently shown to be able to induce the differentiation of recruited monocytes into programmed cell death protein 1 (PD-1) expressing M2-like macrophages, instead of M1 macrophages; in addition to recruiting those monocytes (15).…”

Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review

“…MiR‐643 enhances the sensitivity of breast cancer cells into radiotherapy via STAT3 inhibition (Yang et al, 2020). Furthermore, by down‐regulation of STAT3 signaling pathway, ZIC2 suppresses colony formation of breast cancer cells and is associated with favorable prognosis (Liu et al, 2020). A novel derivative of CT, known as KYZ3 has demonstrated great potential in inhibition of triple negative breast cancer cells.…”

Prognostic Immune-Related Genes of Patients With Ewing’s Sarcoma

“…cancer and exerts a tumor suppressor effect by regulating STAT3 (Liu et al, 2020). Additionally, ZIC2 is used to inhibit breast cancer cell proliferation, migration, and invasion as it is a target gene of miR-1284 (Zhang et al, 2019).…”